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LAY ABSTRACT
Motor deficits in patients with Parkinson’s disease usually 
worsen when tasks are performed simultaneously or un-
der maximal challenge conditions. Assessment of these 
motor complications has an important role in the pre-
diction of fall risk. A range of parameters is used to assess 
motor alterations. Among them, within-subject variation 
is normally used as a parameter of reliability in validation 
studies. Nevertheless, the use of within-subject variation 
during a single session in the Timed Up and Go test with 
the addition of a cognitive dual task (Cognitive TUGwsv) 
performed at maximum speed has not yet been studied 
as a predictor of fall risk in the Parkinson’s disease popu-
lation. The results of this study support the hypothesis 
that a higher Cognitive TUGwsv is related to a higher risk 
of falling in patients with Parkinson’s disease. Therefore, 
health professionals could consider this variable when as-
sessing the risk of falling in this population.
Objective: To explore the use of within-subject va-
riation in the Cognitive Timed Up and Go test (Cogni-
tive TUGWSV) as an explanatory variable in fall risk in 
the Parkinson’s disease population.
Design: Cross-sectional study.
Methods: Fifty-three patients with Parkinson’s di-
sease completed 3 trials of the Cognitive TUGWSV. 
Within-subject variation was calculated using the 
standard deviation of an individual’s repeated mea-
surements, and compared on the basis of the fall his-
tory reported in the previous 6 months. Participants 
who reported < 2 falls were classified as “non-re-
current fallers” (n = 31) and those who reported ≥ 2 
falls were classified as “recurrent fallers” (n = 22). 
Univariate and a multivariate logistic regression 
were used to investigate the statistical impact of the 
Cognitive TUGWSV as an explanatory variable in fall 
risk. Discriminative ability and cut-off score were 
determined based on receiver operating characteris-
tic analysis.
Results: There was a significant difference between 
groups in the Cognitive TUGWSV (p = 0.002). Univariate 
logistic regression indicated a significant association 
between Cognitive TUGWSV and fall risk (χ
2=12.365, 
p < 0.001), with an odds ratio of 2.5 (95% confidence 
interval (95% CI) = 1.34–4.65). Multivariate logis-
tic regression showed that body mass index (BMI), 
Falls Efficacy Scale-International (FES-I), Cognitive 
TUGWSV, and the mean velocity of the centre of foot 
pressure under closed eyes condition (Velocity COP 
(CE)) were significant explanatory variables in fall 
risk. Cognitive TUGWSV was the most important inde-
pendent variable. Receiver operating characteristic 
analysis revealed an acceptable discriminative power 
(area under the curve (AUC) = 0.757, 95% CI = 0.619–
0.864, p < 0.001) and a cut-off point of 1.53 s.
Conclusion: A higher Cognitive TUGWSV correlated sig-
nificantly with higher fall risk. Thus, diagnostic tests 
and exercise programmes could consider Cognitive 
TUGWSV when assessing fall risk in the Parkinson’s 
disease population.
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sease; dual task; postural balance; Timed Up and Go.
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Parkinson’s disease (PD) is a progressive neurodege-nerative disease that encompasses a wide range of 
motor and non-motor symptoms (1). Motor abnorma-
lities include resting tremor, rigidity, bradykinesia, and 
disturbances in gait, balance and posture (2). Among 
them, postural instability and episodic gait disturbances 
are the most debilitating motor symptoms, which are as-
sociated with increased falls, dependence, morbidity and 
mortality (3). Patients with PD are at much higher risk of 
falling than those with other neurological diseases (4); 
hence, early detection of potential fallers is of clinical 
relevance in this population. Several risk factors for fall 
occurrence in patients with PD have been identified: gait 
disorders, increased disease severity, duration of PD, 
Fear of Falling (FoF), cognitive impairment, Freezing of 
Gait (FOG), impaired balance, impaired mobility, redu-
ced muscle strength, and gait disorders (5). Specifically, 
gait disorders include reductions in speed, adaptability, 
step frequency, and step length, as well increased gait 
variability, which worsen with disease severity (6).
There are different types of instruments for assessing 
falls risk in patients with PD: questionnaires, rating 
scales, clinical tests, wearable and non-wearable de-
vices. Within the clinical tests, the Timed Up and Go 
(TUG) test is a clinical timed tool that is used widely 
in the PD population to assess balance and walking 
ability, functional mobility and fall risk, using the time 
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In parallel, some studies have proposed the addition 
of a motor or cognitive task during the performance 
of the TUG test (8), since the ability to simultaneously 
perform multiple tasks is affected in patients with PD 
(9), which could lead to higher risk of falling. Accor-
ding to different studies (8, 10), a cognitive dual-task 
seems to be the best dual-task condition for detecting 
fall risk during TUG performance.
Nevertheless, the exact protocol and the use of cut-
off times as a fall-risk parameter are still under debate, 
with inconsistencies in the literature (11). Technological 
advances have enabled TUG instrument devices, in ad-
dition to measuring the total time, to measure subcom-
ponents of the test with greater accuracy and sensitivity. 
However, practical application of these instruments in 
clinical settings is limited, due to the cost of instruments 
and the excessive time necessary to treat and interpret 
the data (12). Thus, it is of interest to investigate other 
more practical solutions that could increase the limited 
data offered by the original TUG test.
In this sense, variability has normally been used to 
assess the reliability of an instrument (13). Moreover, 
in clinical testing variability has also been used as a 
parameter to assist in the diagnosis of PD (e.g. tapping 
test) (14) or to predict falls (e.g. variability of gait) (15). 
A simple statistic that reveals within-subject variation 
(WSV) on repeated testing is the within-subject stand-
ard deviation (SD) or the SD of an individual’s repeated 
measurements (13). More precisely, in dependent older 
people, the WSV in the TUG test carried out on differ-
ent days at a comfortable speed has shown correlation 
with the time to complete the test (16). However, to 
the authors’ knowledge, the relationship between the 
WSV of the time taken to complete the cognitive TUG 
test (Cognitive TUGwsv) at maximum speed in a single 
session and the risk of falling in the PD population has 
not yet been explored. The use of WSV could be an 
interesting parameter to introduce in the clinical evalu-
ation because of simplicity and rapidity. In addition, 
this parameter could enable intra- and inter-subject 
performance to be merged, in a manner that reduces the 
effect of some non-controllable variables and measures 
the variability of motor performance between trials as a 
potential clinical parameter not previously considered 
in the TUG test score.
Thus, considering that alterations related to motor 
and non-motor symptoms could affect the time needed 
to perform the same action on different attempts, it was 
hypothesized that recurrent fallers should have a higher 
WSV compared with non-recurrent fallers. Moreover, 
these differences would probably be more noticeable if 
the TUG test is performed simultaneously with an added 
cognitive task. Therefore, the aim of this research was to 
explore the relationship between the Cognitive TUGwsv 
and the risk of falling, and to investigate whether this 
parameter could be used as an explanatory parameter 
in fall risk in patients with PD.
METHODS
Participants
The study sample comprised 74 participants, age range 44–84 
years (46 men and 28 women), with confirmed idiopathic PD, 
recruited between February 2018 and September 2019 from 
several PD associations of Alicante, Castellón and Elche, lo-
cated in Comunidad Valenciana, Spain. The sample size was 
chosen based on previous similar research with PD (8), but not 
on statistical considerations. A total of 53 participants met the 
following inclusion criteria: subjects diagnosed with idiopathic 
PD according to the clinical diagnostic criteria of the United 
Kingdom Parkinson’s Disease Society Brain Bank; diagnosed 
by a neurologist; over 18 years of age; Hoehn and Yahr stage 
(H&Y) 1–4; self-reported anti-parkinsonian drugs treatment 
with stable medication for at least 8 weeks before joining the 
study; capable of ambulating independently; able to give infor-
med consent; and able to follow simple instructions. Exclusion 
criteria were: patients with a history of traumatic brain injury 
(TBI) or stroke, severe chronic obstructive pulmonary disease 
(COPD), a neurological disorder other than PD, myocardial 
infarction in the past 12 months, severe orthopaedic problems in 
the lower limbs, and a clinical diagnosis of dementia or severe 
cognitive impairment (Mini-Mental Status Examination Score 
≤24). Selected participants were divided into 2 groups based 
on fall history (number of falls within the previous 6 months). 
Participants who reported fewer than 2 falls were classified as 
“non-recurrent fallers” whereas those who reported 2 or more 
falls were classified as “recurrent fallers”.
Before starting the study, participants were fully informed of 
the aim, benefits and possible risks of participation. Participants 
provided written consent after receiving the project informa-
tion, previously approved by the research ethics committee of 
the University of Alicante (approval number UA-2018-07-11) 
and conducted in accordance with the Declaration of Helsinki. 
All testing procedures took place while participants were in 
the “ON” phase of the medication cycle (i.e. when the medica-
tion is working optimally, usually between 45–90 min after their 
morning dose of dopaminergic medication). 
Procedures
Previous to collecting the data, eligible participants were evalua-
ted by a neurologist and a psychologist to carry out the screening 
process. Participants were evaluated regarding several aspects 
related to PD, including motor and non-motor characteristics.
Potential covariates 
Demographic characteristics were considered as potential co-
variates based on the possible impact on fall risk. Demographic 
characteristics that showed significant differences between non-
recurrent and recurrent fallers were considered as covariates. 
Before carrying out the testing procedures, participants (with the 
help of their relatives) were asked to recall the number of falls 
they had had within the previous 6 months. A fall was defined as 
“an unexpected event, in which the participant comes to rest on 
the ground, floor, or lower level”. The history of falls was used 
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This information was also used to group participants into non-
recurrent fallers (0–1 fall) and recurrent fallers (> 2 falls). The 
history of falls was therefore excluded as a potential covariate, 
since it was used as dependent variable.
Clinical visit
The Spanish version of the modified Unified Parkinson Disease 
Rating Scale motor section (MDS-UPDRS III) was used to 
assess motor symptoms and H&Y staging to assess disease 
severity (17). FoF, conceptualized as concerns about falling, 
was measured using the short version of the Falls Efficacy 
Scale-International (short FES-I) (18). FOG was also reported 
using the Spanish version of the Freezing of Gait Questionnaire 
(FOG-Q) in PD (19). All tests were carried out by a neurologist 
during the clinical visit, prior to the study.
Mental disorders assessment
Cognitive function was evaluated by a psychologist using the 
Mini-Mental Status Examination Score (MMSE) (20), since 
cognitive deficits can be detected even in the early stages of PD. 
Likewise, the MMSE was used to ensure that participants had 
sufficient cognitive function to understand the test procedures.
Motor execution assessment
The Trail Making Test (TMT) was carried out to assess execu-
tive function, cognitive flexibility, and working memory (21). 
Parts A and B of the TMT were evaluated individually, and the 
difference between parts (part B minus part A) determined.
Balance assessment
Posturographic analysis was carried out using a baropodome-
tric platform (FreeMed, Rome, Italy) with an active surface of 
400×400 mm, 8-mm thickness, and a sample frequency of 100 
Hz. Postural sway was measured for 30 s while participants 
stood with open eyes (EO) and closed eyes (CE) conditions 
(quiet stance procedure) (22). The stabilometric parameter 
measured was the mean velocity (Velocity COP), calculated by 
dividing the COP excursion by the trial duration (the lower the 
velocity, the better the postural control). Also, the Functional 
Reach Test (FRT) was performed as a cheaper, easier and rapid 
test to assess dynamic balance (7).
Mobility assessment
The TUG test is the most frequently used tool to assess functional 
mobility in patients with PD. Moreover, it is widely used to assess 
fall risk in this population (23). According to the literature (8), the 
addition of a cognitive task improved the assessment of fall risk. 
Hence, it was decided to perform the TUG test under single and 
dual task condition (semantic verbal fluency task). Participants 
started sitting in a chair, with their back against the chair back and 
their arms resting on the armrests. From this position, they were 
required to get up from the chair, walk 3 m, turn around, walk back 
to the chair and sit down, as quickly as they could safely without 
running. Participants were also asked to complete the TUG test 
while enumerating animal names (24). Any repetition of the same 
animal with a different gender was not allowed within the same trial.
The whole procedure was timed, in s, from the initiation pro-
cess of standing from the chair, after the word “Go”, until the 
participants sat back down in the chair. After a practical trial, 
the mean time and SD of the 3 trials were recorded by 2 cameras 
(model RX100 IV, Sony, Tokyo, Japan). Participants rested for 
1 min between trials and the use of assistant devices was not 
allowed. Time variables were obtained after the post-processing 
of videos (Kinovea 0.8.27 for Windows 10, Bordeaux, France). 
Data analysis
Statistical analyses were conducted using the Statistical Package 
for Social Sciences (IBM, Armonk, NY, USA: IBM Corp). Mean 
and SD were used for descriptive analysis. The Kolmogorov–
Smirnov test was performed to test for normal distribution. 
A χ2 test, independent-samples t-test and Mann–Whitney U 
test were used to identify the variables presenting statistically 
significant differences between non-recurrent and recurrent fal-
lers (p < 0.05), and used as an inclusion criteria in the logistic 
regression analyses. A univariate logistic regression analysis 
was performed to determine the relationship between Cognitive 
TUGwsv (independent variable) and history of falls (dependent 
variable). Moreover, a multivariate logistic regression analysis 
using a backward stepwise selection method (likelihood ratio, 
LR, p < 0.05) was used to investigate the statistical impact of 
the Cognitive TUGwsv combined with covariates in a model in 
which the retrospectively estimated fall risk was the dependent 
variable. Odds ratio (OR), 95% confidence intervals (95% CI) 
and significance were calculated for each variable.
A receiver operating characteristic (ROC) curve was construc-
ted. The area under the ROC curve (AUC) was used to measure 
the accuracy of the Cognitive TUGwsv to discriminate between 
non-recurrent and recurrent fallers. The optimum cut-off point 
was found according to maximum Youden index (sensitivity 
+ specificity –1). An AUC >0.5 to < 0.7 was considered poor 
discrimination, ≥ 0.7 to <0.8 acceptable discrimination, ≥ 0.8 
to < 0.9 excellent discrimination, and ≥ 0.9 outstanding discri-
mination (25).
RESULTS
A total of 53 participants with PD were enrolled in the 
study. Baseline characteristics of the entire cohort, non-
recurrent and recurrent fallers, are shown in Table I. 
The entire cohort had a mean age of 68.9±8.4 years and 
a mean disease duration of 6.3±4.1 years (determined 
from the date of diagnosis of idiopathic PD until the 
date of the study evaluation session). The participants 
had a mean body mass index (BMI) of 26.4±3.6 kg/m2.
Differences between non-recurrent and recurrent 
fallers
There were significant differences between non-recur-
rent and recurrent fallers for different demographic 
characteristics and clinical tests (see Table I). There 
were significant differences between groups in age 
and BMI. Surprisingly, the disease duration in recur-
rent fallers was shorter than in non-recurrent fallers, 
although the difference was not significant (p = 0.163).
On the other hand, the H&Y scale, MDS-UPDRS III, 
short FES-I, FOG-Q, TUG, Cognitive TUG, Cognitive 
TUGwsv, Velocity COP (OE) and Velocity COP (CE) 
showed significant differences between non-recurrent 
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and recurrent fallers. The TMT showed that recurrent 
fallers took more time to complete both sections of 
the test, although there were no significant differences 
between groups. In general, recurrent fallers performed 
significantly poorer than non-recurrent fallers on the 
majority of the motor tests.
As we hypothesized, the Cognitive TUGwsv showed 
a significant difference between groups (p = 0.002). 
The participants who reported more than 1 fall in the 
previous 6 months showed significantly higher mean 
values in the Cognitive TUGwsv. Otherwise, the TUGwsv 
did not show significant differences between groups 
(p = 0.059).
Logistic regression analyses
Model 1: Univariate logistic regression. In order to 
analyse if the Cognitive TUGwsv was associated with 
fall risk, a univariate logistic regression was performed. 
The results showed a significant association between 
Cognitive TUGwsv and fall risk (χ
2 = 12.365, p < 0.001) 
with an OR of 2.50 (95% CI = 1.34–4.65, p = 0.004). 
The proposed model correctly classified 71.7% of the 
overall participants. 
Model 2: Multivariate logistic regression. A multi-
variate logistic regression using backward stepwise 
selection method (LR) was performed adjusting for 
all study covariates that showed significant differences 
between groups (Table II).
BMI, Short FES-I, FOG-Q, Cognitive TUGwsv and 
Velocity COP (CE) were included in the last step of the 
logistic regression analysis. Of these, only the FOG-Q 
was excluded as significant explanatory variable in 
fall risk (p > 0.05). In our model, the strongest variable 
was the Cognitive TUGwsv, which means that if the 
Cognitive TUGwsv increased by 1 s, the odds of being 
a recurrent faller would be 2.47 times higher (95% CI 
1.15–5.31, p = 0.021).
Model 2 also indicated that the included variables 
significantly explained fall risk (χ2 = 33.613, df = 5 and 
p < 0.001). Our model correctly classified 83% of the 
overall participants.
Discriminative performance of the Cognitive TUGwsv 
ROC analysis was conducted to assess the accuracy of 
the Cognitive TUGwsv to discriminate between non-re-










  Sex, men/women 37/16 24/7 13/9 0.152
  Age, years 68.9±8.4 67±9 71.4±6.7 0.035*
  Disease duration, years 6.3±4.1 6.9±4.1 5.4±3.9 0.163
  BMI, kg/m2 26.4±3.6 25.4±3.3 27.9±3.5 0.012*
  History of falls, number of events 2.2±2.7 0.5±0.5 4.6±2.7 0.001*
Clinical tests
  H&Y (1–5) 2.1±0.9 1.9±0.7 2.5±1 0.024*
  MDS-UPDRS-III (0–132) 32.3±18 27±15.3 39.8±19.1 0.009*
  Short FES-I (7–28) 13.1±4.8 11.2±3.5 15.8±5.3 0.001*
  MMSE (0–30) 26.9±1.8 27.5±2.2 26.1±3.4 0.122
  FOG-Q (0–24) 7.7±5.4 6.4±4.5 9.7±5.4 0.033*
  TMT A, s 67.76±52.31 58.16±33.72 81.30±69.45 0.376
  TMT B, s 171.45±122.48 149.52±99.26 202.36±146.16 0.220
  TMT (B-A) , s 103.69±81.44 91.37±73.40 121.06±90.48 0.304
  FRT, cm 20.53±6.02 21.06±6.62 19.79±5.11 0.594
  TUG, s 11.67±4.60 9.90±2.28 14.17±5.82 0.004*
  TUGWSV 0.50±0.34 0.43±0.31 0.60±0.36 0.059
  Cog TUG, s 16.83±9.18 13.31±4.79 21.79±11.47 0.002*
  Cog TUGWSV, s 1.46±1.32 0.94±0.80 2.15±1.56 0.002*
  Velocity COP (OE), mm/s 15.92±5.68 14.18±3.90 18.38±6.88 0.011*
  Velocity COP (CE), mm/s 17.86±7.72 16.02±6.92 20.45±8.19 0.017*
*Significant difference at p < 0.05
U: Mann–Whitney U test; t: independent-samples t-test; BMI: body mass index; H&Y: Hoehn & Yahr scale; MDS-UPDRS (III): Modified Unified Parkinson Disease 
Rating Scale; Short FES-I: short version of Falls Efficacy Scale-International; MMSE: Mini-Mental Scale Examination; FOG-Q: Freezing of Gait Questionnaire; TMT 
A: Trail Making Test part A; TMT B: Trail Making Test part B; FRT: Functional Reach Test; TUG: Timed Up and Go test; TUGWSV: Within-Subject Variation in the 
Timed Up and Go test; Cognitive TUG: time to complete the Time Up and Go test with an added cognitive task; Cognitive TUGWSV: Within-Subject Variation in 
the Timed Up and Go test with an added cognitive task; Velocity COP (OE): mean velocity of the centre of foot pressure (Open Eyes); Velocity COP (CE): mean 
velocity of the centre of foot pressure (Closed Eyes).
Table II. Model 2: multivariate logistic regression analysis with 
fall risk as the dependent variable
OR 95% CI p-value
BMI 1.38 1.05–1.81 0.022*
Short FES-I 1.43 1.04–1.97 0.026*
FOG-Q 0.79 0.59–1.04 0.098
Cognitive TUGWSV 2.47 1.15–5.31 0.021*
Velocity COP (CE) 1.28 1.05–1.55 0.013*
*p: significant difference at p < 0.05. OR: odds ratio; CI: confidence interval; 
BMI: body mass index; Short FES-I: short version of Falls Efficacy Scale-
International; FOG-Q: Freezing of Gait Questionnaire; Cognitive TUGWSV: Within-
Subject Variation in the Timed Up and Go test with an added cognitive task; 
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current and recurrent fallers. The results showed an ac-
ceptable AUC value of 0.757 (95% CI = 0.619–0.864, 
p < 0.001) (Fig. 1). The highest Youden index was 0.52 
with a cut-off point of 1.53 s (sensitivity = 68.18%; 
specificity = 83.87%).
DISCUSSION
The novel approach of this study was to analyse the re-
lationship between fall risk and Cognitive TUGwsv within 
the same session in a PD population. The results showed 
that Cognitive TUGwsv was the strongest explanatory 
variable in fall risk, with acceptable accuracy in distin-
guishing between non-recurrent and recurrent fallers.
Previous to the logistic regression analyses, com-
parative statistics showed that there were significant 
differences between groups for different demographic 
characteristics and clinical tests. According to our 
hypothesis, the Cognitive TUGwsv showed significant 
differences between non-recurrent and recurrent fall-
ers. Conversely, the TUGwsv did not show significant 
differences between groups, although the p-value 
was close to significance (p = 0.059). The significant 
difference detected in the Cognitive TUGwsv could be 
explained by attention deficits elicited by the dual-
task performance of the test, which can lead to major 
changes in gait variability and stability (26) and the 
occurrence of more freezing episodes compared with 
single-task conditions (27).
The results of model 1 (univariate) showed a signi-
ficant association between the Cognitive TUGwsv and 
fall risk. For each 1-s increase in the Cognitive TUGwsv 
the odds of being a recurrent-faller would be 2.5 times 
higher. Therefore, a multivariate logistic regression 
analysis was performed to confirm if the Cognitive 
TUGwsv could be used as an explanatory variable in 
fall risk when other potential variables were taken 
into account. The variables that showed significant 
differences between groups (p < 0.05) were entered into 
the regression analysis. However, some relevant tests, 
such as the TMT scores (p = 0.220–0.376), MMSE 
(p = 0.122) and the FRT (p = 0.594), were excluded, de-
spite being widely used tools (7, 28). Previous studies, 
such as that by Chen et al. (29), reported a significant 
association between cognitive tests and fall risk, but 
these measurements were not explanatory variables of 
prospective falls after considering other risk factors, 
specially psychomotor tests. The use of cognitive de-
terioration as an exclusion criteria in the majority of 
the studies, including in the current study (MMSE), 
could have influenced the relationship between cog-
nitive impairment and fall risk (28). In the case of the 
FRT, the instrument fulfils the criteria of being recom-
mended by the Movement Disorders Society Rating 
Scales Committee, although its relationship with fall 
occurrence in PD population is uncertain (7).
Model 2 (multivariate) showed that BMI, short FES-
I, Cognitive TUGwsv and Velocity COP (CE) were sig-
nificant explanatory variables in fall risk. Specifically, 
Cognitive TUGwsv was the most important independent 
variable (OR = 2.47, 95% CI = 1.15–5.31, p = 0.021). 
ROC analysis indicated an acceptable discriminative 
power of the Cognitive TUGwsv (AUC = 0.757, 95% 
CI = 0.619–0.864, p < 0.001) and a cut-off point of 1.53 
s. This means that a patient who reported a higher WSV 
than the cut-off point would have an increased risk of 
being a recurrent faller.
The TUG test, performed under single- and dual-task 
conditions, is used in the literature as a tool to assess 
functional mobility and to identify patients with PD 
who are at risk of falling (7, 23). However, no studies 
have reported information related to Cognitive TUGwsv 
during a single session. Therefore, it is complex to 
compare the current results with those of other studies, 
because most of the studies compared trials between 
data groups, trials performed in different medication 
states (30), or trials performed in different days (31). 
Moreover, the WSV information provided in the stu-
dies are usually founded as a mean time of trials or, 
conversely, only a single trial was used to perform the 
TUG test.
It is usual to find variability in repeated measures, 
due to the participant, the evaluator, or the precision 
of the instrument (32). The main source of this va-
riability is usually biological; for example, changes 
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in the mental or physical state of the participant (13) 
although mechanical variations, learning or fatigue 
effects should be also considered in patients with PD. 
Taking into account that PD is related to motor and 
non-motor symptoms, these alterations could explain 
the higher Cognitive TUGwsv found in the recurrent 
faller group.
The relationship between Cognitive TUGwsv and fall 
risk might be attributed to different factors. The most 
crucial could be the abnormal gait pattern found in 
patients with PD (33), characterized by small shuff-
ling steps, hesitation, slowing of gait and reduced 
arm swing, sometimes combined with festination or 
FOG episodes. The difficulties of patients with PD in 
motor planning, particularly when they have to initiate 
locomotion or negotiate a turn, along with the impaired 
ability of dual tasking could influence gait performance 
and the appearance of FOG episodes and festination, 
which are strongly correlated with falls (27). Further-
more, the unexpected nature and duration of FOG 
episodes and festination could result in an increase 
in Cognitive TUGwsv. In the case of Cognitive TUG, 
the influence of the different sub-tasks of which it is 
composed (sit, sit to stand, walk, turn, walk-back and 
sit-back) and the addition of the verbal fluency task 
should be taken into account to explain the WSV. The 
sub-task of getting up from the chair, including the 
stability during the lift-off phase as a consequence of 
the movement preparation to get up, requires sufficient 
muscle strength in the lower limbs especially at the 
hip, which could increase the Cognitive TUGwsv (34). 
Consequently, different attempts or longer periods 
could be needed to get up from the chair. Another 
relevant point could be the maximum speed employed 
in the TUG test because of the impairment observed 
in patients with PD in automatic and rapid alternating 
movements (35) or when the tests were carried out at 
maximal challenge (36). Indeed, Van Uem et al. (37) 
observed that the TUG test performed at maximum 
speed differentiated mild to moderate patients better 
than when it was performed at a comfortable speed. 
Other disturbances related to motor performance, such 
as dysfunction of the internal clock rhythm observed 
in patients with PD, could also affect the Cognitive 
TUGwsv and alter the results (38).
Various factors can also influence the displacement 
capability and, consequently, the Cognitive TUGwsv 
including impaired balance, medication state, depres-
sion and stressful situations (2, 30). 
All of the above can make it very challenging for 
a patient with PD to maintain a similar performance 
between trials. Consequently, it is reasonable that the 
most affected patients showed higher values of Cog-
nitive TUGwsv . Therefore, apart from using the time 
to complete the test, it would be necessary to consider 
WSV when assessing fall risk in a PD population.
On the other hand, BMI was reported in model 2 as 
a significant variable associated with risk of falling. 
Non-recurrent fallers showed a significantly lower 
BMI (25.4±3.3 kg/m2) compared with recurrent-fallers 
(27.9±3.5 kg/m2). It is well known that an increased 
BMI is correlated with poor health status, frailty, in-
activity, fall risk and poor quality of life (39). Hence, 
it makes sense that the participants with the highest 
values of BMI reported a significant increase in fall 
risk. The short FES-I was also included in the final 
model as a significant explanatory variable in fall risk. 
Generally, FoF is associated with gait and balance 
problems, reduced mobility and poorer health and 
quality of life among others (40). This could result in 
a spiralling risk of increasing falls, FoF and functional 
decline (41). Therefore, the current results were in line 
with previous studies, which indicated that FoF was 
correlated with fall occurrence (42). Static posturo-
graphy is a widely used technique to assess balance 
performance and fall risk in PD populations (22). 
Gervasoni et al. (43) identified body sway velocity as 
the best posturographic variable to predict recurrent 
falls in PD, although contradictory results have been 
reported in the literature in this regard (22). 
Conversely, the FOG-Q was included in the final 
step of model 2, although it was not a significant ex-
planatory variables of fall risk. Together with previous 
research (44), the current study showed the relevance 
of the presence of FOG as a potential variable in fall 
risk assessment, since significant differences between 
non-recurrent and recurrent fallers were found. Despite 
the well-known relationship between FOG and fall 
risk, the exclusion of this parameter as a significant 
explanatory variable (p = 0.069) in the final step of 
model 2 could be due to the episodic nature of FOG, 
the “ON” medication state at testing, and the use of 
cognitive or compensatory mobility strategies to over-
come freezing events (45). 
Study limitations
This study has some limitations. First, it has a small 
sample size, which did not allow for generalization. 
Increasing the sample size in future studies would also 
enable the assessment and comparison of different PD 
phenotypes.
A second limitation was the disease severity in the 
sample. The majority of the sample were patients with 
mild to moderate PD. Future studies should examine 
the Cognitive TUGwsv in patients with advanced PD, 
in whom this factor could be more relevant for the as-
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to explore whether the Cognitive TUGwsv is sensitive to 
changes in medication states or changes due to physical 
therapy programmes. Thirdly, a methodological limita-
tion was the use of the MMSE test to assess cognitive 
function instead of the MoCA test, which is more app-
ropriate to this aim. Another methodological limitation 
was the retrospective classification of non-recurrent 
and recurrent fallers, since prospective recording is the 
reference standard for assessment of fall risk.
Finally, despite the use of a practical trial, a small 
learning effect could have occurred between trials 1 
and 2, according to the literature (30). Alternatives, 
such as increasing the number of repetitions, were 
not considered, because they were not practical solu-
tions, and would have resulted in more fatigue among 
participants. 
Conclusion
Cognitive TUGwsv was a significant explanatory 
variable in fall risk among patients with PD, with 
an acceptable accuracy in distinguishing between 
non-recurrent and recurrent fallers. The results of the 
current study also support the use of BMI, the short 
FES-I and velocity COP (CE) as significant explana-
tory variables in fall risk.
Overall, these results support the idea that a higher 
Cognitive TUGwsv is related to a higher risk of falls 
in patients with PD. Thus, if the current results are 
confirmed in future studies, diagnostic tests and ex-
ercise programmes could consider this cheap, quick 
and simple parameter when assessing the risk of fall 
in patients with PD.
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